本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cullinan Therapeutics

8.28
+0.38004.81%
盘后8.280.00000.00%16:02 EDT
成交量:35.81万
成交额:290.59万
市值:4.84亿
市盈率:-2.66
高:8.41
开:7.79
低:7.70
收:7.90
数据加载中...
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report